Rheumatoid arthritis: open trials in Spain

28 open trials have a site in Spain. Registry data; only the trial team decides who can take part.

NCT07295847
A Study of AZD0120 in Autoimmune Diseases
Trial Treatment · Phase 1/2 · AstraZeneca
Barcelona · Madrid
Registry updated 2026-11-02
NCT07363590
A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)
Trial Treatment · Phase 1 · Merck Sharp & Dohme LLC
Clinica Universidad de Navarra, Madrid · Clínica Universidad de navarra, Pamplona · Complexo Hospitalario Universitario De Santiago, Santiago de Compostela
Registry updated 2026-11-02
NCT07201558
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
Trial Treatment · Phase 1 · AstraZeneca
Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Universitario Reina Sofia, Córdoba · Hospital Universitario Ramón y Cajal, Madrid
Registry updated 2026-10-28
NCT07412704
A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
Trial Treatment · Phase 1/2 · Bristol-Myers Squibb
Complexo Hospitalario Universitario A Coruña, A Coruña · Hospital Universitario Reina Sofia, Córdoba
Registry updated 2026-10-23
NCT06916806
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
Trial Treatment · Phase 1 · AstraZeneca
Hospital de Mérida, Mérida · Hospital Quironsalud Infanta Luisa, Sevilla · Hospital Universitario Rio Hortega, Valladolid
Registry updated 2026-10-19
NCT07473154
Controlling Hyperactive Immunity With Long-lived Lymphocytes
Trial Treatment · Phase 1/2 · Quell Therapeutics Limited
Hospital Universitario Fundación Jiménez Díaz, Madrid
Registry updated 2026-10-19
NCT07137598
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
Trial Treatment · Phase 2 · Hoffmann-La Roche
Complejo Hospitalario Universitario A Coruña, La Corua · Hospital Regional Universitario de Malaga, Málaga · Complejo Hospitalario Universitario de Santiago, Santiago de Compostela · Hospital Universitario Virgen Macarena, Seville · Hospital Quironsalud Infanta Luisa, Seville
Registry updated 2026-10-16
NCT07620392
An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis
Trial Treatment · Phase 2 · Hoffmann-La Roche
Complexo Hospitalario Universitario A Coruña, A Coruña · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario Reina Sofia, Córdoba · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario Regional de Málaga, Málaga · Complexo Hospitalario Universitario De Santiago, Santiago de Compostela · Hospital Quironsalud Infanta Luisa, Sevilla · Hospital Universitario Virgen De La Macarena, Sevilla
Registry updated 2026-10-16
2025-523971-46-00
Study QEL-005-CLN-01. Phase I/II study of QEL-005 in patients with diffuse cutaneous systemic sclerosis (dcSSc) and in patients with difficult to treat rheumatoid arthritis (D2TRA).
Trial Treatment · Phase 1/2 · Quell Therapeutics Limited
Hospital Universitario Fundación Jiménez Díaz, Madrid
Registry updated 2026-10-15
NCT07276581
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
Trial Treatment · Phase 2 · AstraZeneca
Barcelona · Málaga · Sabadell · Santiago de Compostela · Valencia
Registry updated 2026-10-09
NCT06972446
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
Trial Treatment · Phase 2 · AbbVie
Complexo Hospitalario Universitario A Coruña, A Coruña · Hospital Universitario Basurto, Bilbao · Hospital Universitario Reina Sofia, Córdoba · Hospital General Universitario Gregorio Marañón, Madrid · Parc Tauli Hospital Universitari, Sabadell · Hospital Universitario Marqués de Valdecilla, Santander · Hospital Universitario Virgen De Valme, Sevilla · Consorcio Hospital General Universitario de Valencia, Valencia
Registry updated 2026-10-08
2025-522076-85-00
A study to investigate how well and safe a trial drug called AZD1163, administered as an injection, works in improving symptoms and inflammation in adult participants with moderately to severely active rheumatoid arthritis.
Trial Treatment · Phase 2 · AstraZeneca AB
Hospital del Mar, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Universitario Regional de Málaga, Málaga · Parc Tauli Hospital Universitari, Sabadell · Complexo Hospitalario Universitario De Santiago, Santiago de Compostela · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-10-07
NCT06570798
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
Trial Treatment · Phase 2 · Amgen
Hospital Clínic i Provincial de Barcelona, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Marqués de Valdecilla, Santander
Registry updated 2026-10-05
2025-524005-32-00
A study to assess the safety and efficacy of different doses of ELV001 to treat active rheumatoid arthritis in patients with an inadequate response to methotrexate and tumor necrosis factor inhibition (START SYNERGY)
Trial Treatment · Phase 2 · Elevara Medicines Limited
Sanitas S.A. De Hospitales, Barcelona · Hospital Universitario Basurto, Bilbao · Hospital Universitario Lucus Augusti, Lugo · Hospital Universitario 12 de Octubre, Madrid
Registry updated 2026-09-21
NCT05691868
Vantage Mobile Bearing Total Ankle System Post Market Clinical Follow-up (Outside US)
Research · Exactech
Hospital Universitario de Canarias, Santa Cruz de Tenerife
Registry updated 2026-09-16
2025-521034-28-00
A Study to Assess the Efficacy and Safety of RO7790121 in Patients with Moderate to Severe Rheumatoid Arthritis who have not Responded to or who Cannot Tolerate TNF and/or JAK Inhibitors
Trial Treatment · Phase 2 · F. Hoffmann-La Roche AG
Complexo Hospitalario Universitario A Coruña, A Coruña · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario Reina Sofia, Córdoba · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario Regional de Málaga, Málaga · Complexo Hospitalario Universitario De Santiago, Santiago de Compostela · Hospital Quironsalud Infanta Luisa, Sevilla · Hospital Universitario Virgen De La Macarena, Sevilla
Registry updated 2026-09-14
2024-511470-79-00
3TR-PARTNER-RA
Trial Treatment · Phase 4 · Queen Mary University Of London
Hospital Clinic de Barcelona, Barcelona · Hospital Universitario Reina Sofia, Córdoba
Registry updated 2026-09-09
2025-523127-21-00
A Study to Evaluate Targeted Therapies for Patients with Rheumatoid Arthritis
Trial Treatment · Phase 1 · AbbVie Deutschland GmbH & Co. KG
Hospital Universitario Reina Sofia, Córdoba · Parc Tauli Hospital Universitari, Sabadell · Hospital Universitario Virgen De Valme, Sevilla
Registry updated 2026-09-01
NCT07760662
Oxidative Stress and Cardiovascular Risk in Patients With Rheumatoid Arthritis
Research · University of La Laguna
Hospital Universitario de Canarias, Santa Cruz de Tenerife
Registry updated 2026-08-12
2022-502021-18-00
The 3TR Molecular Pathobiology-Driven Precision Therapy in RA (3TR Precis-The-RA) study
Trial Treatment · Phase 4 · Queen Mary University Of London
Area Sanitaria Da Coruna E Cee, A Coruna · Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer, Barcelona · Hospital Universitario Reina Sofia, Córdoba
Registry updated 2026-08-05
NCT06991114
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Trial Treatment · Phase 2 · Artiva Biotherapeutics, Inc.
Hospital Quironsalud Infanta Luisa, Sevilla
Registry updated 2026-07-31
2024-518011-19-01
Testing the safety and efficacy of combining biologic drugs in Rheumatoid and Psoriatic Arthritis
Trial Treatment · Phase 2 · Cardiff University
Hospital Germans Trias i Pujol, Badalona · Hospital Universitari Vall d'Hebron, Barcelona
Registry updated 2026-07-14
NCT07115745
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
Trial Treatment · Phase 1 · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario Ramón y Cajal, Madrid
Registry updated 2026-07-14
NCT07678112
Medical Device for Sustained Remission in Rheumatoid Arthritis Treated With Biological Therapy
Trial Treatment · Francisco J. Blanco
Complejo Hospitalario Universitario de A Coruña, A Coruña · Hospital Universitario Araba, Alava · Hospital del Mar, Barcelona · Hospital Universitario la Princesa, Madrid · Hospital Universitario 12 de Octubre, Madrid · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Clínico San Carlos, Madrid · Hospital Regional Universitario de Malaga, Málaga · Hospital Universitario de Canarias, San Cristóbal de La Laguna
Registry updated 2026-07-01
NCT07371468
A Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)
Trial Treatment · Phase 1 · GlaxoSmithKline
Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Universitario La Paz, Madrid · Hospital Clínico San Carlos, Madrid · Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda
Registry updated 2026-06-23

All Rheumatoid arthritis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error